Objection pursuant to Rule 112 (2) and (3): Active substances, including 8-hydroxyquinoline, chlorotoluron and difenoconazole — B9-0460/2022 — Proposal for a resolution · Vote

Vote · Roll call

Objection pursuant to Rule 112 (2) and (3): Active substances, including 8-hydroxyquinoline, chlorotoluron and difenoconazole — B9-0460/2022 — Proposal for a resolution

Vote: Objection pursuant to Rule 112 (2) and (3): Active substances, including 8-hydroxyquinoline, chlorotoluron and difenoconazole — B9-0460/2022 — Proposal for a resolution
Decision: Not linked to a decision
Result: 349 for · 275 against · 14 abstained · roll call
Date: 18 October 2022, 13:21

More facts (2)

Official label: Objection pursuant to Rule 112 (2) and (3): Active substances, including 8-hydroxyquinoline, chlorotoluron and difenoconazole - B9-0460/2022 - Proposal for a resolution
Vote id: 149085

Official label: Objection pursuant to Rule 112 (2) and (3): Active substances, including 8-hydroxyquinoline, chlorotoluron and difenoconazole - B9-0460/2022 - Proposal for a resolution
Vote id: 149085

Cite this page

The members file includes members in office who did not vote.

Roll-call results (EP)

Link to this page

Result

The vote as recorded by name.

· 55 % of the votes cast were for.

Groups

Members counted in their current group: the view with groups at the date of the vote is not available right now.

Members’ votes by their current group. Majority: the most common position. Clear line: a position with at least two thirds of the group’s votes, otherwise Divided.
Group	For	Against	Abst.	Majority line	Clear line
S&D	For 58	Against 2	Abst. 4	Majority line For	Clear line For
EPP	For 16	Against 74	Abst. 3	Majority line Against	Clear line Against
The Left	For 13	Against 0	Abst. 0	Majority line For	Clear line For
ECR	For 1	Against 24	Abst. 1	Majority line Against	Clear line Against
Greens	For 27	Against 0	Abst. 0	Majority line For	Clear line For
Renew	For 26	Against 12	Abst. 0	Majority line For	Clear line For
No group	For 4	Against 0	Abst. 0	Majority line —	Clear line No line
ESN	For 1	Against 2	Abst. 0	Majority line Against	Clear line Against
Patriots	For 0	Against 27	Abst. 0	Majority line Against	Clear line Against

Countries × groups

How each country’s members of each group voted.

The breakdown by country is not available right now.

Members

Each member’s recorded position — groups as of today: the view with groups at the date of the vote is not available right now.

Show all 638 members

No vote recorded

Members in office that day without a recorded position. No vote recorded is not the same as absent: leave, illness or chairing the sitting look the same.

The list of members without a recorded position is not available right now.

Similar votes

Roll calls that split the chamber the most similarly: r is the correlation of members’ positions, over the members who voted in both. Other votes on the same decision are left out.

Similar votes are not available right now.

Compare with another vote

Groups’ lines side by side, and the members who switched between the two votes.

Connections

This vote’s decision, the other votes on it, and related votes.

No connections found for this vote.

Sources & citation

Where the facts on this page come from, and how to cite it.

Permalink: https://news.eu-parl.st-solutions.dev/votes/2022-10-18/149085
Official sources: Roll-call votes, sitting of 18 October 2022 (European Parliament)
Results of votes, sitting of 18 October 2022 (European Parliament)
Data source: EP Open Data API: vote results of the sitting MTG-PL-2022-10-18
Licensed CC BY 4.0.
Retrieved: 27 September 2026

Cite as

European Parliament (2022). “Objection pursuant to Rule 112 (2) and (3): Active substances, including 8-hydroxyquinoline, chlorotoluron and difenoconazole — B9-0460/2022 — Proposal for a resolution”. Vote, 18 October 2022. votingId 149085. EU Parl Watch Research. https://news.eu-parl.st-solutions.dev/votes/2022-10-18/149085 (retrieved 27 September 2026). Official sources: Roll-call votes, sitting of 18 October 2022 (European Parliament), https://www.europarl.europa.eu/doceo/document/PV-10-2022-10-18-RCV_EN.html; Results of votes, sitting of 18 October 2022 (European Parliament), https://www.europarl.europa.eu/doceo/document/PV-10-2022-10-18-VOT_EN.html. Data: EP Open Data API: vote results of the sitting MTG-PL-2022-10-18, https://data.europarl.europa.eu/api/v2/meetings/MTG-PL-2022-10-18/vote-results?format=application%2Fld%2Bjson (CC BY 4.0).

BibTeX

@misc{epw-vote-2022-10-18-149085,
  author = {{European Parliament}},
  title = {{Objection pursuant to Rule 112 (2) and (3): Active substances, including 8-hydroxyquinoline, chlorotoluron and difenoconazole — B9-0460/2022 — Proposal for a resolution}},
  year = {2022},
  date = {2022-10-18},
  howpublished = {\url{https://news.eu-parl.st-solutions.dev/votes/2022-10-18/149085}},
  url = {https://news.eu-parl.st-solutions.dev/votes/2022-10-18/149085},
  urldate = {2026-09-27},
  publisher = {EU Parl Watch Research},
  note = {Vote. votingId 149085. Official source: https://www.europarl.europa.eu/doceo/document/PV-10-2022-10-18-RCV\_EN.html, https://www.europarl.europa.eu/doceo/document/PV-10-2022-10-18-VOT\_EN.html. Data: EP Open Data API: vote results of the sitting MTG-PL-2022-10-18 (CC BY 4.0)}
}